|
Ixazomib Clinical Trials
5 actively recruiting trials across 3 locations
Also known as: Ninlaro, Ninlaro®
Pipeline
Phase 2: 1Phase 4: 1Phase 1/2: 3
Top Sponsors
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
- Rajshekhar Chakraborty, MD1
- Karyopharm Therapeutics Inc1
- Ho Sup Lee1
- CellCentric Ltd.1
Indications
- Cancer5
- Multiple Myeloma3
- Higher-risk Myelodysplastic Syndrome1
- Peripheral T Cell Lymphoma1
- AL Amyloidosis1
Other2 trials
Gilbert, Arizona1 trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Banner MD Anderson Cancer Center
Phase 1/2
Atlanta, Georgia1 trial
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Emory Winship Cancer Institute
Phase 1/2
Boston, Massachusetts1 trial
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Boston Medical Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.